Singapore, Feb. 24 -- The International Vaccine Institute (IVI) has opened its new Biorepository, a global centre for biological resources, at its headquarters in Seoul, South Korea. The new facility in the annex building of the IVI headquarters complex is expected to play a pivotal role in acquiring, preserving, and distributing pathogens and samples for research globally in support of IVI's mission and contributing to the development of vaccines, diagnostics, and therapeutics for global health.

The completion of the IVI Biorepository is timely and significant. As an international organisation devoted to vaccine research for global public health, IVI is working in more than 50 countries worldwide, conducting extensive research including...